Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Amortizatization of Intangibles: 2015-2019

Historic Amortizatization of Intangibles for Ocular Therapeutix (OCUL) over the last 2 years, with Jun 2019 value amounting to $143,000.

  • Ocular Therapeutix's Amortizatization of Intangibles was N/A to $143,000 in Q2 2019 from the same period last year, while for Jun 2019 it was $347,000, marking a year-over-year change of. This contributed to the annual value of $17,000 for FY2017, which is 90.86% down from last year.
  • Per Ocular Therapeutix's latest filing, its Amortizatization of Intangibles stood at $143,000 for Q2 2019, which was down 23.53% from $187,000 recorded in Q1 2019.
  • In the past 5 years, Ocular Therapeutix's Amortizatization of Intangibles registered a high of $470,000 during Q4 2015, and its lowest value of -$148,000 during Q3 2015.
  • In the last 2 years, Ocular Therapeutix's Amortizatization of Intangibles had a median value of $77,000 in 2017 and averaged $86,750.
  • Examining YoY changes over the last 5 years, Ocular Therapeutix's Amortizatization of Intangibles showed a top increase of 677.78% in 2016 and a maximum decrease of 97.23% in 2016.
  • Ocular Therapeutix's Amortizatization of Intangibles (Quarterly) stood at $470,000 in 2015, then tumbled by 97.23% to $13,000 in 2016, then tumbled by 87.76% to $6,000 in 2017, then reached $143,000 in 2019.
  • Its last three reported values are $143,000 in Q2 2019, $187,000 for Q1 2019, and $6,000 during Q2 2017.